BioXcel Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD from Q1 2019 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary
BioXcel Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and growth rate from Q1 2019 to Q2 2025.
  • BioXcel Therapeutics, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending June 30, 2025 was $5K, a 83.3% decline year-over-year.
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2025 $5K -$25K -83.3% Jun 30, 2025 10-Q 2025-08-12
Q1 2025 $9K -$31K -77.5% Mar 31, 2025 10-Q 2025-05-12
Q4 2024 $17K -$34K -66.7% Dec 31, 2024 10-K 2025-03-28
Q3 2024 $22K -$40K -64.5% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $30K -$45K -60% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $40K -$49K -55.1% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $51K -$53K -51% Dec 31, 2023 10-K 2024-03-22
Q3 2023 $62K -$58K -48.3% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $75K -$61K -44.9% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $89K -$66K -42.6% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $104K -$70K -40.2% Dec 31, 2022 10-K 2023-03-16
Q3 2022 $120K -$73K -37.8% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $136K -$77K -36.2% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $155K -$80K -34% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $174K -$76K -30.4% Dec 31, 2021 10-K 2022-03-11
Q3 2021 $193K -$68K -26.1% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $213K +$64K +43% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 $235K +$86K +57.7% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $250K +$89K +55.3% Dec 31, 2020 10-K 2021-03-12
Q3 2020 $261K +$88K +50.9% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $149K -$37K -19.9% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 $149K -$49K -24.7% Mar 31, 2020 10-Q 2020-05-12
Q4 2019 $161K Dec 31, 2019 10-K 2020-03-09
Q3 2019 $173K Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $186K Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $198K Mar 31, 2019 10-Q 2019-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.